Addressing Drug-Related Side Effects in Children With Congenital Heart Disease: A Policy Brief.
作者信息
Toni Esmaeel, Ayatollahi Haleh
机构信息
Iran University of Medical Sciences, Tehran, Iran.
出版信息
Glob Pediatr Health. 2024 Oct 23;11:2333794X241291398. doi: 10.1177/2333794X241291398. eCollection 2024.
Abstract
摘要
相似文献
1
Addressing Drug-Related Side Effects in Children With Congenital Heart Disease: A Policy Brief.应对先天性心脏病患儿的药物相关副作用：政策简报
Glob Pediatr Health. 2024 Oct 23;11:2333794X241291398. doi: 10.1177/2333794X241291398. eCollection 2024.
2
Radiofrequency catheter ablation of tachycardia in patients with congenital heart disease.先天性心脏病患者心动过速的射频导管消融术。
Pediatr Cardiol. 2000 Nov-Dec;21(6):557-75. doi: 10.1007/s002460010134.
3
Ethics priorities in adult congenital heart disease.成人先天性心脏病的伦理重点。
Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):266-273.e3. doi: 10.1016/j.pcad.2012.10.004.
4
Why should we care about ethical and policy challenges in congenital heart disease?我们为什么要关注先天性心脏病中的伦理和政策挑战？
World J Pediatr Congenit Heart Surg. 2013 Jan;4(1):7-9. doi: 10.1177/2150135112454666.
5
Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease.吸入一氧化氮对先天性心脏病患儿肺动脉高压的影响。
Br Heart J. 1994 Mar;71(3):282-6. doi: 10.1136/hrt.71.3.282.
6
Occupational performance challenges for children with congenital heart disease: a literature review.
Can J Occup Ther. 2004 Jun;71(3):161-72. doi: 10.1177/000841740407100306.
7
Evaluation of Oral Health Status and Treatment Needs of Children with Congenital and Acquired Heart Disease.先天性和后天性心脏病患儿口腔健康状况及治疗需求评估
J Clin Med. 2024 Jul 11;13(14):4060. doi: 10.3390/jcm13144060.
8
Addressing violence against children: A case review in the state of Qatar.应对儿童暴力：卡塔尔的案例审查。
Front Public Health. 2022 Dec 6;10:859325. doi: 10.3389/fpubh.2022.859325. eCollection 2022.
9
[Recommendations of the Spanish Society of Paediatric Cardiology and Congenital Heart Disease as regards the use of drugs in attention deficit hyperactivity disorder in children and adolescents with a known heart disease, as well as in the general paediatric population: Position statement by the Spanish Paediatric Association].[西班牙儿科心脏病学和先天性心脏病学会关于已知患有心脏病的儿童和青少年以及普通儿科人群注意力缺陷多动障碍用药的建议：西班牙儿科学会立场声明]
An Pediatr (Engl Ed). 2020 Feb;92(2):109.e1-109.e7. doi: 10.1016/j.anpedi.2019.09.002. Epub 2019 Oct 30.
10
Effects of sugammadex on postoperative respiratory management in children with congenital heart disease: a randomized controlled study.苏伽达格对先天性心脏病患儿术后呼吸管理的影响：一项随机对照研究。
Biomed Pharmacother. 2020 Jul;127:110180. doi: 10.1016/j.biopha.2020.110180. Epub 2020 Apr 27.
引用本文的文献
1
Drug-Related Side Effects and Contributing Risk Factors in Children With Congenital Heart Disease: A Cross-Sectional Study.先天性心脏病患儿的药物相关副作用及相关危险因素：一项横断面研究
Health Sci Rep. 2025 May 19;8(5):e70835. doi: 10.1002/hsr2.70835. eCollection 2025 May.
本文引用的文献
1
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review.先天性心脏病儿童的药物不良反应：系统评价。
Paediatr Drugs. 2024 Sep;26(5):519-553. doi: 10.1007/s40272-024-00644-8. Epub 2024 Jul 23.
2
Health Equity and Policy Considerations for Pediatric and Adult Congenital Heart Disease Care among Minoritized Populations in the United States.美国少数族裔人群中儿童及成人先天性心脏病护理的健康公平性与政策考量
J Cardiovasc Dev Dis. 2024 Jan 25;11(2):36. doi: 10.3390/jcdd11020036.
3
E-Health: A Game Changer in Fetal and Neonatal Cardiology?电子健康：胎儿与新生儿心脏病学的变革者？
J Clin Med. 2023 Oct 30;12(21):6865. doi: 10.3390/jcm12216865.
4
Recommendations for developing effective and safe paediatric and congenital heart disease services in low-income and middle-income countries: a public health framework.为中低收入国家制定有效和安全的儿科及先天性心脏病服务的建议：公共卫生框架。
BMJ Glob Health. 2023 May;8(5). doi: 10.1136/bmjgh-2023-012049.
5
Global, regional, and national time trends in mortality for congenital heart disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.1990 - 2019年先天性心脏病死亡率的全球、区域和国家时间趋势：全球疾病负担2019研究的年龄-时期-队列分析
EClinicalMedicine. 2022 Jan 11;43:101249. doi: 10.1016/j.eclinm.2021.101249. eCollection 2022 Jan.
6
Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future.医疗保健政策与先天性心脏病：2020 聚焦我们的 2030 未来。
J Am Heart Assoc. 2021 Oct 19;10(20):e020605. doi: 10.1161/JAHA.120.020605. Epub 2021 Oct 8.
7
Empowering Young Persons with Congenital Heart Disease: Using Intervention Mapping to Develop a Transition Program - The STEPSTONES Project.赋能先天性心脏病青年患者：运用干预映射方法开发一项过渡项目——STEPSTONES 项目。
J Pediatr Nurs. 2020 Jan-Feb;50:e8-e17. doi: 10.1016/j.pedn.2019.09.021. Epub 2019 Oct 25.
8
Risk assessment of patient factors and medications for drug-related problems from a prospective longitudinal study of newborns admitted to a neonatal intensive care unit in Brazil.巴西新生儿重症监护病房前瞻性纵向研究中与药物相关问题的患者因素和药物的风险评估。
BMJ Open. 2019 Jul 10;9(7):e024377. doi: 10.1136/bmjopen-2018-024377.
9
Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.儿科心脏病患者心肺复苏：美国心脏协会科学声明。
Circulation. 2018 May 29;137(22):e691-e782. doi: 10.1161/CIR.0000000000000524. Epub 2018 Apr 23.
10
Critical Congenital Heart Disease Newborn Screening Implementation: Lessons Learned.危重新生儿先天性心脏病筛查实施：经验教训
Matern Child Health J. 2017 Jun;21(6):1240-1249. doi: 10.1007/s10995-017-2273-4.
Zotero 插件